WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.28%)Nav, as on 07-03-2025

  • Previous Nav

  • Net Change on 07-03-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI -8.29 -10.99 13.97 21.13 23.90 15.26
BSE SENSEX - TRI -4.47 -8.90 1.51 13.47 16.00 13.27

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 9.24 19.89 23.87 1.82 8,160.74
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 16.41 24.48 26.63 1.93 4,917.81
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 17.63 24.32 25.27 1.94 3,521.93
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 12.59 21.18 24.82 1.91 3,197.52
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 11.98 18.21 23.66 1.94 2,652.24

Fund Holdings as on 28-February-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Max Healthcare Institute Limited

  • Divi's Laboratories Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Clearing Corporation of India Ltd

  • Torrent Pharmaceuticals Limited

  • Krishna Institute Of Medical Sciences Limited

  • Mankind Pharma Limited

  • Apollo Hospitals Enterprise Limited

  • Laurus Labs Limited

  • IPCA Laboratories Limited

  • Abbott India Limited

  • Ajanta Pharma Limited

  • Piramal Pharma Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Poly Medicure Limited

  • Biocon Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Global Health Limited

  • Jupiter Life Line Hospitals Limited

  • Vijaya Diagnostic Centre Limited

  • Neuland Laboratories Limited

  • Rainbow Childrens Medicare Limited

  • Eris Lifesciences Limited

  • Ami Organics Limited

  • Navin Fluorine International Limited

  • 91 Days Tbill (MD 08/05/2025)

  • Supriya Lifescience Limited

  • AstraZeneca Pharma India Limited

  • Strides Pharma Science Limited

  • Kovai Medical Center and Hospital Limited

  • RPG Life Sciences Limited

  • Thyrocare Technologies Limited

  • Laxmi Dental Limited

  • 364 Days Tbill (MD 23/05/2025)

  • Blue Jet Healthcare Ltd

  • Sai Life Sciences Limited

  • Net Receivables / (Payables)

  • SRF Limited

  • Sanofi Consumer Healthcare India Limited

  • Shaily Engineering Plastics Limited

  • Dr.Agarwals Eye Hospital Limited

  • 91 Days Tbill (MD 20/03/2025)

  • 91 Days Tbill (MD 10/04/2025)

  • 91 Days Tbill (MD 17/04/2025)

  • Zota Health Care Limited

  • 91 Days Tbill (MD 24/04/2025)

  • 364 Days Tbill (MD 13/03/2025)

  • 91 Days Tbill (MD 28/03/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Plastic Products

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹271.36 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.03(-0.28%)yesterday to ₹12.154.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643